0001493152-22-001279.txt : 20220114
0001493152-22-001279.hdr.sgml : 20220114
20220114162017
ACCESSION NUMBER: 0001493152-22-001279
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211228
FILED AS OF DATE: 20220114
DATE AS OF CHANGE: 20220114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Levine Jon R
CENTRAL INDEX KEY: 0001789645
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54433
FILM NUMBER: 22532098
MAIL ADDRESS:
STREET 1: C/O MARIMED INC.
STREET 2: 10 OCEANA WAY
CITY: NORWOOD
STATE: MA
ZIP: 02062
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MARIMED INC.
CENTRAL INDEX KEY: 0001522767
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 274672745
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 OSSIPEE RD
STREET 2: SUITE 201
CITY: NEWTON
STATE: MA
ZIP: 02464
BUSINESS PHONE: 617-795-5140
MAIL ADDRESS:
STREET 1: 26 OSSIPEE RD
STREET 2: SUITE 201
CITY: NEWTON
STATE: MA
ZIP: 02464
FORMER COMPANY:
FORMER CONFORMED NAME: WORLDS ONLINE INC.
DATE OF NAME CHANGE: 20110608
4
1
ownership.xml
X0306
4
2021-12-28
0
0001522767
MARIMED INC.
MRMD
0001789645
Levine Jon R
C/O MARIMED INC.
10 OCEANA WAY
NORWOOD,
MA
02062
1
1
0
0
CFO, Treasurer and Secretary
Common stock
2021-12-28
4
M
0
100000
0.63
A
20085343
D
Common stock
2021-12-28
4
F
0
76226
0.86
D
20012117
D
Common stock
6684640
I
By the Jon Levine Family Trust
Option to buy common stock
0.63
2021-12-28
4
M
0
100000
0
D
2021-12-31
Common Stock, par value $.001 per share
100000
0
D
Option to buy common stock
0.898
2026-10-01
Common Stock, par value $.001 per share
5000000
5000000
D
Option to buy common stock
0.88
2026-07-09
Common Stock, par value $.001 per share
5000000
5000000
D
These shares are held in trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Immediately.
Exercisable to acquire 50% of the underlying shares on the July 9, 2021 and 100% of the shares on or after July 9, 2022.
/s/ Jon R. Levine
2022-01-14